Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01362374
Title Safety and Pharmacology Of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR | FRA | ESP

Facility Status City State Zip Country Details
California Pacific Med Center San Francisco California 94115 United States Details
Florida Cancer Specialists - Sarasota Sarasota Florida 34232 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
University Of Michigan Ann Arbor Michigan 48109 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89128 United States Details
SCRI Nashville Tennessee 37203 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
Institut Gustave Roussy; Departement Oncologie Medicale Villejuif 94805 France Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
Hospital Clinico Universitario de Valencia Valencia 46010 Spain Details
The Royal Marsden Hospital Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field